Back to MREO

UBS Group AG → MREO

UBS Group AG MREO Position History

Mereo BioPharma Group plc • Healthcare

Quarters held
19
Latest value
$25K
Q3 2026
Peak value
$1.3M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$19K
Q3 2025$638K
Q3 2025$1.3M
Q3 2025$22K
Q4 2025$5K
Q4 2025$61K
Q4 2025$551K
Q4 2025$33K
Q1 2026$2K
Q1 2026$481K
Q1 2026$1K
Q1 2026$8K
Q2 2026$2K
Q2 2026$427K
Q2 2026$31K
Q3 2026$2K
Q3 2026$110K
Q3 2026$8K
Q3 2026$25K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$25K61.4K——
Q3 2026$8K19.8K——
Q3 2026$110K273.9K——
Q3 2026$2K5.9K——
Q2 2026$31K97.5K——
Q2 2026$427K1.34M——
Q2 2026$2K5.9K——
Q1 2026$8K23.9K——
Q1 2026$1K3.1K——
Q1 2026$481K1.46M——
Q1 2026$2K5.9K——
Q4 2025$33K78.5K——
Q4 2025$551K1.32M——
Q4 2025$61K146.9K——
Q4 2025$5K11.8K——
Q3 2025$22K10.6K——
Q3 2025$1.3M641.3K——
Q3 2025$638K309.7K——
Q3 2025$19K9.0K——

Other funds holding MREO

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B